SCHEMBL183909

SCHEMBL183909

CN(C)C=NC(N)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL183908 1.00
SCHEMBL14421414 1.00
SCHEMBL16526158 0.80
SCHEMBL13301079 0.77 SMN1; SMN2 (0.42)
SCHEMBL3102738 0.77 SMN1; SMN2 (0.42)
SCHEMBL4430295 0.72
SCHEMBL21118496 0.72
SCHEMBL21014214 0.72
SCHEMBL4097383 0.72
SCHEMBL4430293 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115845818-B Lignin grafted N- [ (dimethylamino) methylene ] thiourea type heavy metal adsorbent and preparation method and application thereof 南京工业大学 2024-02-23 CN claimed
CN-115845818-A Lignin grafted N- [ (dimethylamino) methylene ] thiourea heavy metal adsorbent and preparation method and application thereof 南京工业大学 2023-03-28 CN claimed
CN-114555568-A Preparation of 2-chloro-1- (2-chlorothiazol-5-yl) ethanone 巴斯夫欧洲公司 2022-05-27 CN claimed
US-20260027089-A1 MrgprX2 Antagonists for the Treatment of Inflammatory Disorders DERMIRA INC (US) 2026-01-29 US disclosed
US-12502380-B2 MrgprX2 antagonists for the treatment of inflammatory disorders DERMIRA, INC. (US) 2025-12-23 US disclosed
WO-2025130765-A1 COMPOUNDS, COMPOSITIONS AND METHODS THEREOF HEPAITECH (BEIJING) BIOPHARMA TECHNOLOGY CO., LTD. (CN) 2025-06-26 WO disclosed
WO-2025066935-A1 COMPOUNDS, COMPOSITIONS AND METHODS THEREOF HEPAITECH (BEIJING) BIOPHARMA TECHNOLOGY CO., LTD. (CN) 2025-04-03 WO disclosed
US-20250057816-A1 MrgprX2 Antagonists for the Treatment of Inflammatory Disorders DERMIRA, INC. 2025-02-20 US disclosed
CN-114845709-B MRGPRX2 antagonists for the treatment of inflammatory disorders 德米拉公司 2024-10-01 CN disclosed
CN-115845818-B Lignin grafted N- [ (dimethylamino) methylene ] thiourea type heavy metal adsorbent and preparation method and application thereof 南京工业大学 2024-02-23 CN disclosed
CN-115845818-B Lignin grafted N- [ (dimethylamino) methylene ] thiourea type heavy metal adsorbent and preparation method and application thereof 南京工业大学 2024-02-23 CN disclosed
WO-2005077945-A2 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-08-25 WO disclosed
WO-2005076990-A2 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-CARBOXAMIDES USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-08-25 WO disclosed
US-20050176965-A1 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2005-08-11 US disclosed
EP-1539722-A1 THIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-06-15 EP disclosed
US-20040038990-A1 Aminothiazole derivatives HOFFMANN-LA ROCHE INC. 2004-02-26 US disclosed
WO-2004014884-A1 THIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-02-19 WO disclosed
EP-0072755-B1 CEPHALOSPORIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM RHONE-POULENC SANTE (FR) 1985-08-21 EP disclosed
US-4496560-A ACTIVE AGAINST GRAMPOSITIVE BACTERIA RHONE-POULENC SANTE (FR) 1985-01-29 US disclosed
EP-0072755-A1 Cephalosporin derivatives, their preparation and pharmaceutical compositions containing them RHONE-POULENC SANTE (FR) 1983-02-23 EP disclosed